TrialBMC complementary and alternative medicine2011

Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma--a prospective open clinical trial.

Markus A Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.